KO’ZNING SHOX PARDASI VA OLDINGI SEGMENTI PATOLOGIYASINI DAVOLASHDA SKLERAL LINZALARNING TERAPEVTIK QO’LLANILISHI

KO’ZNING SHOX PARDASI VA OLDINGI SEGMENTI PATOLOGIYASINI DAVOLASHDA SKLERAL LINZALARNING TERAPEVTIK QO’LLANILISHI

Авторы

  • M. A. Kadirova Doktor Maksudova innovatsion klinikasi
  • F. A. Baxritdinova Toshkent tibbiyot akademiyasi https://orcid.org/0000-0001-6252-3622
  • B. B. Xadjimuxamedov Toshkent pediatriya tibbiyot instituti

DOI:

https://doi.org/10.57231/j.ao.2023.1.1.049

Ключевые слова:

skleral linzalari, keratit, yuqumli keratit, miniskleral linzalar, shox parda patologiyasi

Аннотация

Dolzarbligi. Ko’zning shox pardasi va oldingi segmenti patologiyasini davolashda skleral linzalarning terapevtik qo’llanilishi 1980‑yillarning oxiridan boshlab skleral linzalar shox parda patologiyasi, ko’zning oldingi segmenti kasalliklarini davolashda faol ishlatilgan. Skleral linzalar oddiy mahalliy tomchilardan shox parda va paralimbal epiteliyga ta’siri, uzoq muddatli gidratatsiya effekti bilan farq qiladi. Terapevtik tomondan skleral linzalar birdaniga ikkta vazifani ta’minlashi mumkin: ular ko’z yuzasini himoya qiladi va epiteliyning notekisligi mavjud bo’lgan kasallarda ko’rish o’tkirligini tiklaydi. Tadqiqot maqsadi. Mumkin bo'lgan jarrohlik aralashuvlarni kechiktirish imkonini beruvchi, shuningdek, yuqumli keratit va shox parda epiteliya nuqsonlarini davolashda shox parda patologiyasini davolashning mustaqil usuli sifatida skleral linzalarning samaradorligini aniqlash. Material va usullar. Maqolada ko’zning shox pardasi va oldingi segmenti patologiyasini davolashda skleral linzalarning terapevtik qo’llanilishiga oid masalalarni aks ettiruvchi 2013 yildan boshlab ohirgi xorijiy ilmiy nashrlar analizi qilindi. Natija. Skleral linzalarning uzluksiz gidratatsiyani ta’minlash qobiliyati, ko’z yuzasini namlash va himoya qilish, bemorlarga ko’rish o’tkirligini saqlashga imkon beradi va ularning terapiyaning boshqa shakllari bilan birgalikda qo’llash mumkin bo’lganligi ularni og’ir ko’z yuzasi kasalliklari uchun samarali davolash variantiga aylantiradi.

Биографии авторов

M. A. Kadirova, Doktor Maksudova innovatsion klinikasi

Oftalmolog

F. A. Baxritdinova, Toshkent tibbiyot akademiyasi

Tibbiyot fanlari doktori, Oftalmologiya kafedrasi professori

B. B. Xadjimuxamedov, Toshkent pediatriya tibbiyot instituti

Оftalmologiya kafedrasi mustaqil izlanuvchisi

Библиографические ссылки

Schornack MM. Scleral lenses: a literature review. Eye & Contact Lens. 2015;41(1):3–11. doi: 10.1097/ICL.0000000000000083.

Fadel D, Kramer E. Potential contraindications to scleral lens wear. Cont Lens & Anterior Eye. 2019;42(1):92–103. doi:3. 10.1016/j.clae.2018.10.024.

Fedotova K, Graboveckij VR, Novikov SA, Ezugbaya M. Miniscleral contact lenses in the treatment of patients with dry eye syndrome (first personal experience). Oftal’mologicheskie vedomosti. 2019;12(1):5–12. (In Russ.). doi: 10.17816/OV1215-12

Alipour F, Kheirkhah A, Jabarvand Behrouz M. Use of miniscleral contact lenses in moderate to severe dry eye. Cont Lens & Anterior Eye. 2012;35(6):272–6. doi: 10.1016/j. clae.2012.07.006.

Bavinger JC, DeLoss K, Mian SI. Scleral lens use in dry eye syndrome. Curr Opin Ophthalmol. 2015;26(4):319–24. doi: 10.1097/ICU.0000000000000171.

Jones L, Downie LE, Korb D, et al. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017;15(3):575–628.doi: 10.1016/j.jtos.2017.05.006.

Tougeron-Brousseau B, Delcampe A, Gueudry J, et al. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Am J Ophthalmol. 2009;148(6):852–9. e2. doi: 10.1016/j.ajo.2009.07.006.

Foulks GN, Forstot SL, Donshik PC, et al. Clinical guidelines for management of dry eye associated with Sjögren disease. Ocul Surf. 2015;13(2):118–32.doi: 10.1016/j.jtos.2014.12.001.

Grey F, Carley F, Biswas S, Tromans C. Scleral contact lens management of bilateral exposure and neurotrophic keratopathy. Cont Lens & Anterior Eye. 2012;35(6):288–91. doi: 10.1016/j.clae.2012.07.009.

Weyns M, Koppen C, Tassignon MJ. Scleral contact lenses as an alternative to tarsorrhaphy for the long-term management of combined exposure and neurotrophic keratopathy. Cornea. 2013;32(3):359–61. doi: 10.1097/ICO.0b013e31825fed01 PMID:23073486.

Sabesan R, Johns L, Tomashevskaya O, et al. Wavefrontguided scleral lens prosthetic device for keratoconus. Optom Vis Sci. 2013;90:314–323. doi: 10.1097/OPX.0b013e318288d19c.

Rathi VM, Mandathara PS, Dumpati S. Contact lens in keratoconus. Indian J Ophthalmol. 2013;61:410–415.doi: 10.4103/0301-4738.116066.

Pullum K, Anand V. Scleral lenses for keratoconus and corneal transplant. Cont Lens & Anterior Eye. 2013;36: e14. doi: 10.1016/j.clae.2013.08.059 .

Arumugam AO, Rajan R, Subramanian M, et al. PROSE for irregular corneas at a tertiary eye care center. Eye & Contact Lens. 2014;40:71–73. doi: 10.1097/ICL.0000000000000006.

Mahadevan R, Fathima A, Rajan R, et al. An ocular surface prosthesis for keratoglobus and Terrien’s marginal degeneration. Optom Vis Sci. 2014;91(1): S34-S39. doi: 10.1097/OPX.0000000000000200.

DeLoss KS, Fatteh NH, Hood CT. Prosthetic replacement of the ocular surface ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia. Am J Ophthalmol. 2014;158:974–982. doi: 10.1016/j. ajo.2014.07.016.

Rathi VM, Murthy SI, Bagga B, et al. Keratoglobus: An experience at a tertiary eye care center in India. Indian.

J Ophthalmol. 2015;63:233–238. doi: 10.4103/0301-4738.156927.

Asena L, Altinors DD. Clinical outcomes of scleral Misa lenses for visual rehabilitation in patients with pellucid marginal degeneration. Cont Lens & Anterior Eye. 2016;39:420–424.doi: 10.1016/j.clae.2016.06.010.

Gupta N, Ganger A. Keratoglobus. A close entity to megalophthalmos. Springerplus. 2016;5:634. doi: 10.1186/s40064–016–2307–1.

Rathi VM, Dumpati S, Mandathara PS, et al. Scleral contact lenses in the management of pellucid marginal degeneration.

Cont Lens & Anterior Eye. 2016;39(3):217–20. doi: 10.1016/j.clae.2015.11.005 PMID: 26669275.

Polania-Baron EJ, Santana-Cruz O, Lichtinger A, et al. Treatment of Severe Infectious Keratitis With Scleral Contact Lenses as a Reservoir of Moxifloxacin 0.5. Cornea. 2021;40(7):831–836. doi: 10.1097/ICO.0000000000002482 PMID: 32833847.

Macedo-de-Araújo RJ, McAlinden C, van der Worp E, González-Méijome JM. Improvement of Vision and Ocular Surface Symptoms With a Scleral Lens After Microbial Keratitis. Eye & Contact Lens. 2021;47(8):480–483. doi: 10.1097/ICL.0000000000000794 PMID: 3392892326.

Agzamova SS. Improvement of diagnostics and treatment of ophthalmic complications in zygomatic and orbital injuries. «Ophthalmology. Eastern Europe». 2021;11.3:311–320 (In Russ.)] https://doi.org/10.34883/PI.2021.11.3.030.

Тuychibaeva Д. M. Longitudinal changes in the disability due to glaucoma in Uzbekistan // J.ophthalmol. (Ukraine). 2022;507.4:12–17. http://doi.org/10.31288/oftalmolzh202241217.

Yangieva NR, Rizaev ZhA, Lokes EP. Development of a method for predicting the risk of occurrence and early detection of age-related macular degeneration of the retina. Bulletin of problems of biology and medicine. 2020;1(50):260–264.

Загрузки

Опубликован

2023-02-22

Выпуск

Раздел

Статьи
Loading...